Abstract
Growth failure is a common and complicated process in children with cystic fibrosis (CF). Growth hormone, which is becoming a more commonly used agent in such patients, has demonstrated beneficial effects aside from increased growth velocity. Recently, insulin-like growth factor-1 has gained significant attention in the understanding of growth failure in children with CF. We report the successful prolonged use of recombinant human insulin-like growth factor-1 in an adolescent boy with CF, who demonstrated significant clinical benefits from the therapy.
Original language | English |
---|---|
Pages (from-to) | 1137-1141 |
Number of pages | 5 |
Journal | Pediatric Pulmonology |
Volume | 46 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 2011 |
Keywords
- cystic fibrosis
- growth failure
- growth hormone
- insulin-like growth factor